187 related articles for article (PubMed ID: 29437617)
21. Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.
Lee BJ; Rao SN; Wang SK; Lee JY; Lakada IY; Gilbert EM; Barr VO; Postelnick MJ; Sutton SH; Zembower TR; Bolon M; Scheetz MH; Rhodes NJ
Int J Antimicrob Agents; 2017 May; 49(5):650-654. PubMed ID: 28279787
[TBL] [Abstract][Full Text] [Related]
22. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
Davis JS; Turnidge J; Tong S
Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
[TBL] [Abstract][Full Text] [Related]
23. Comparison of penicillins (penicillin G and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia in Japan: a retrospective cohort study.
Moriyama Y; Ishikane M; Mezaki K; Ohmagari N
J Infect Chemother; 2020 Apr; 26(4):358-362. PubMed ID: 31822451
[TBL] [Abstract][Full Text] [Related]
24. The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.
Flynt LK; Kenney RM; Zervos MJ; Davis SL
Infect Dis Ther; 2017 Jun; 6(2):225-231. PubMed ID: 28265972
[TBL] [Abstract][Full Text] [Related]
25. Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis.
Yetmar ZA; Razi S; Nayfeh T; Gerberi DJ; Mahmood M; Abu Saleh OM
Int J Antimicrob Agents; 2022 Jan; 59(1):106486. PubMed ID: 34839007
[TBL] [Abstract][Full Text] [Related]
26. Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation.
Antosz K; Battle S; Chang J; Scheetz MH; Al-Hasan M; Bookstaver PB
Pharmacotherapy; 2023 Jan; 43(1):85-95. PubMed ID: 36521869
[TBL] [Abstract][Full Text] [Related]
27. Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia.
Weis S; Kesselmeier M; Davis JS; Morris AM; Lee S; Scherag A; Hagel S; Pletz MW
Clin Microbiol Infect; 2019 Jul; 25(7):818-827. PubMed ID: 30928559
[TBL] [Abstract][Full Text] [Related]
28. Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections.
Rao SN; Rhodes NJ; Lee BJ; Scheetz MH; Hanson AP; Segreti J; Crank CW; Wang SK
Antimicrob Agents Chemother; 2015 Sep; 59(9):5232-8. PubMed ID: 26077253
[TBL] [Abstract][Full Text] [Related]
29. Antistaphylococcal penicillins versus cephalosporins for definitive treatment of meticillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
Vardakas KZ; Apiranthiti KN; Falagas ME
Int J Antimicrob Agents; 2014 Dec; 44(6):486-92. PubMed ID: 25311850
[TBL] [Abstract][Full Text] [Related]
30. Comparative Effectiveness of Exclusive Exposure to Nafcillin or Oxacillin, Cefazolin, Piperacillin/Tazobactam, and Fluoroquinolones Among a National Cohort of Veterans With Methicillin-Susceptible
Beganovic M; Cusumano JA; Lopes V; LaPlante KL; Caffrey AR
Open Forum Infect Dis; 2019 Jul; 6(7):ofz270. PubMed ID: 31281864
[TBL] [Abstract][Full Text] [Related]
31. Cefazolin versus cloxacillin as definitive antibiotic therapy for methicillin-susceptible Staphylococcus aureus spinal epidural abscess: a retrospective cohort study.
Bai AD; Findlater A; Irfan N; Singhal N; Loeb M
Int J Antimicrob Agents; 2021 Nov; 58(5):106429. PubMed ID: 34469802
[TBL] [Abstract][Full Text] [Related]
32. Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.
Loubet P; Burdet C; Vindrios W; Grall N; Wolff M; Yazdanpanah Y; Andremont A; Duval X; Lescure FX
Clin Microbiol Infect; 2018 Feb; 24(2):125-132. PubMed ID: 28698037
[TBL] [Abstract][Full Text] [Related]
33. The Cost-effectiveness of Cefazolin Compared With Antistaphylococcal Penicillins for the Treatment of Methicillin-Sensitive
Pliakos EE; Ziakas PD; Mylonakis E
Open Forum Infect Dis; 2021 Nov; 8(11):ofab476. PubMed ID: 34746331
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Cosgrove SE; Sakoulas G; Perencevich EN
BMC Infect Dis; 2011 Oct; 11():279. PubMed ID: 22011388
[TBL] [Abstract][Full Text] [Related]
35. Cefazolin Versus Anti-Staphylococcal Penicillins for the Treatment of Patients with Methicillin-Susceptible Staphylococcus aureus Infection: A Meta-Analysis with Trial Sequential Analysis.
Allen JM; Bakare L; Casapao AM; Klinker K; Childs-Kean LM; Pomputius AF
Infect Dis Ther; 2019 Dec; 8(4):671-686. PubMed ID: 31392580
[TBL] [Abstract][Full Text] [Related]
36. Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible
Ganguly A; de la Flor C; Alvarez K; Brown LS; Mang NS; Smartt J; King H; Perl TM; Filizola H; Bhavan KP
Ann Pharmacother; 2023 Apr; 57(4):425-431. PubMed ID: 35942602
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of cloxacillin versus cefazolin for methicillin-susceptible
Burdet C; Loubet P; Le Moing V; Vindrios W; Esposito-Farèse M; Linard M; Ferry T; Massias L; Tattevin P; Wolff M; Vandenesch F; Grall N; Quintin C; Mentré F; Duval X; Lescure FX;
BMJ Open; 2018 Sep; 8(8):e023151. PubMed ID: 30173161
[TBL] [Abstract][Full Text] [Related]
38. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS).
Timbrook TT; McKay L; Sutton JD; Spivak ES
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844017
[TBL] [Abstract][Full Text] [Related]
39. Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?
Karchmer AW
Clin Infect Dis; 2017 Jul; 65(1):107-109. PubMed ID: 28379366
[No Abstract] [Full Text] [Related]
40. Prevalence and Characterization of the Cefazolin Inoculum Effect in North American Methicillin-Susceptible Staphylococcus aureus Isolates.
Dingle TC; Gamage D; Gomez-Villegas S; Hanson BM; Reyes J; Abbott A; Burnham CD; Dien Bard J; Fritz S; Miller WR; Westblade LF; Zimmer B; Arias CA; Butler-Wu S;
J Clin Microbiol; 2022 Jul; 60(7):e0249521. PubMed ID: 35578988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
